<DOC>
	<DOCNO>NCT01172782</DOCNO>
	<brief_summary>The purpose study evaluate adequate dose intrathecal hydromorphone injection postoperative pain relief knee arthroscopic surgery .</brief_summary>
	<brief_title>The Analgesic Effect Intrathecal Hydromorphone Injection Spinal Anesthesia</brief_title>
	<detailed_description>Sixty patient undergoing unilateral knee arthroscopy randomly receive unilateral spinal anesthesia 0.5 % hyperbaric bupivacaine 6 mg combine normal saline 0.05 mL hydromorphone 2.5 , 5 , 10 Î¼g/0.05 mL . The verbal numerical rating scale ( VNRS ) pain score measure 30 minute 2 , 4 , 6 , 12 24 hour postoperatively , side effect hydromorphone record .</detailed_description>
	<mesh_term>Hydromorphone</mesh_term>
	<criteria>ASA class III ( age range : 1872 year ) Informed consent obtain patient The exclusion criterion include evidence neurological neuromuscular disease , respiratory cardiac disease , diabetes mellitus peripheral neuropathy , well patient receive chronic analgesic therapy infection intend site spinal needle insertion hypersensitivity amide local anesthetic opioids</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>72 Years</maximum_age>
	<verification_date>January 2010</verification_date>
</DOC>